Isotretinoin, the drug most people still call Accutane, is the most effective medical treatment for severe acne and the only one that can produce lasting remission after a finite course. It is also one of the most heavily regulated oral drugs prescribed to otherwise healthy young people, because of a well-established teratogenic risk and a set of monitoring requirements. It overlaps with the looksmaxing and androgen-using world for two reasons: severe acne is a common side effect of anabolic steroid use, and skin clarity is a core aesthetic goal. This guide covers what the evidence actually supports.
What it is and how it works
Isotretinoin is 13-cis-retinoic acid, an oral vitamin A derivative (a retinoid). It is the only acne treatment that acts on all four drivers of acne at once: it dramatically shrinks sebaceous glands and cuts sebum (oil) production, normalizes the shedding of skin cells that clog pores, reduces the acne-associated bacterium Cutibacterium acnes indirectly by removing its oily environment, and lowers inflammation. The sebum suppression is the key mechanism and explains both its effectiveness and most of its side effects.
The efficacy
Isotretinoin is highly effective for nodulocystic and treatment-resistant acne. A standard course delivers a cumulative dose (historically targeted around 120-150 mg per kilogram of body weight total) over roughly 4-9 months. Most patients clear substantially, and a large fraction achieve long-term remission after a single course; the rest may relapse to some degree and a minority need a second course. No other acne therapy reliably produces durable remission after stopping. That combination of high clearance and lasting effect is why it remains first-line for severe disease despite its burdens.
The predictable side effects
Because it suppresses sebum and affects all skin and mucous membranes, some effects are near-universal and dose-related rather than rare complications:
- Dry lips, dry skin, dry eyes, and dry nasal passages (nosebleeds) are expected and manageable.
- Temporary acne flaring in the first weeks is common.
- Muscle and joint aches, especially in physically active people, which matters for lifters and athletes.
- Increased sun sensitivity.
- Reduced night vision in some people.
The monitoring that matters
Isotretinoin requires baseline and periodic laboratory monitoring, and this is not optional box-ticking:
- Lipids: it commonly raises triglycerides and, less often, cholesterol. Marked triglyceride elevations are the main metabolic concern and are checked before and during treatment.
- Liver: transaminases (ALT/AST) can rise; liver enzymes are monitored, though clinically significant hepatotoxicity is uncommon.
- Pregnancy: for anyone who can become pregnant, pregnancy testing is mandatory before, during, and after treatment.
- Practical note: alcohol compounds the lipid and liver load, and the muscle effects are amplified by heavy training, so intensity is often dialed back during a course.
Teratogenicity and iPLEDGE
The single most important fact about isotretinoin is that it is a potent teratogen: exposure during pregnancy causes a high rate of severe birth defects and pregnancy loss. There is no safe dose in pregnancy. In the United States this risk is managed through iPLEDGE, a federally mandated risk-management program that requires registration, two forms of contraception for those who can become pregnant, regular negative pregnancy tests, and monthly attestations before each prescription can be filled. Other countries run comparable pregnancy-prevention programs. None of this reflects a risk to a future pregnancy after the drug clears the body reasonably soon after stopping; the danger is exposure during treatment, which is why the controls are so strict.
The mood question, honestly
Whether isotretinoin causes depression, mood changes, or suicidal thoughts is one of the most studied and least settled controversies in dermatology. A fair summary of the current evidence:
- Large population studies and several systematic reviews have not established that isotretinoin raises the rate of depression or suicide at the group level; some data even show acne itself is associated with depression, and clearing it can improve mood.
- Despite that, regulators worldwide keep mood, depression, and suicidal ideation on the label because individual case reports, rechallenge cases (symptoms returning when the drug is restarted), and a plausible biological pathway cannot be dismissed.
- The reasonable interpretation is that a causal population-level effect has not been demonstrated, but a susceptibility in some individuals cannot be excluded, so monitoring mood during a course is sensible rather than alarmist.
Bottom line
Isotretinoin is uniquely effective for severe acne and the only treatment that can produce lasting remission, which is why it stays first-line despite everything around it. The costs are predictable dryness and aches, real lipid and liver effects that require lab monitoring, and an absolute, non-negotiable teratogenic risk managed through iPLEDGE-type programs. The mood question remains genuinely open: not proven at the population level, not safely dismissed at the individual one. This is reference information, not medical advice.